A Case of Metaplastic Breast Cancer with Prolonged Response to Single Agent Liposomal Doxorubicin

Female breast cancer accounts for 14% of all new cancer cases in the United States. Metaplastic breast carcinomas (MpBC) are less than 1% of all mammary tumors. Limited clinical information exists on the prognosis and treatments for MpBC due to its rarity and the histological diversity of the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamad, Lamya, Khoury, Thaer, Vona, Karen, Nestico, Jill, Opyrchal, Mateusz, Salerno, Kilian E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752368/
https://www.ncbi.nlm.nih.gov/pubmed/26918222
http://dx.doi.org/10.7759/cureus.454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752368/
https://www.ncbi.nlm.nih.gov/pubmed/26918222
http://dx.doi.org/10.7759/cureus.454

Ejemplares similares